PD-1 and CTLA-4: Two checkpoints, one pathway?

被引:17
|
作者
Walker, Lucy S. K. [1 ]
机构
[1] UCL, Div Infect & Immun, Inst Immun & Transplantat, Royal Free Campus, London NW3 2PF, England
基金
英国医学研究理事会;
关键词
T-CELLS; CD28;
D O I
10.1126/sciimmunol.aan3864
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Transcriptional regulation of the immune checkpoints PD-1 and CTLA-4
    Guo, Jing
    Xue, Zhonghui
    Wang, Lie
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (07) : 861 - 862
  • [2] Transcriptional regulation of the immune checkpoints PD-1 and CTLA-4
    Jing Guo
    Zhonghui Xue
    Lie Wang
    Cellular & Molecular Immunology, 2022, 19 : 861 - 862
  • [3] CTLA-4 and PD-1 pathway blockade: combinations in the clinic
    Callahan, Margaret K.
    Postow, Michael A.
    Wolchok, Jedd D.
    FRONTIERS IN ONCOLOGY, 2015, 4
  • [4] Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression
    Skafi, Najwa
    Fayyad-Kazan, Mohammad
    Badran, Bassam
    GENE, 2020, 754
  • [5] Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma
    Landwehr, Laura-Sophie
    Altieri, Barbara
    Sbiera, Iuliu
    Remde, Hanna
    Kircher, Stefan
    Olabe, Julie
    Sbiera, Silviu
    Kroiss, Matthias
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (09): : 2325 - 2334
  • [6] Inhibiting CTLA-4 and PD-1 Boosts Response
    不详
    CANCER DISCOVERY, 2013, 3 (07) : 710 - 711
  • [7] Uveal consequences of CTLA-4 and PD-1 inhibition
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [8] PD-1, CTLA-4 Point to Drug Response
    Landhuis, Esther
    CANCER DISCOVERY, 2016, 6 (11) : 1201 - 1201
  • [9] MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
    Touchaei, Arefeh Zabeti
    Vahidi, Sogand
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [10] MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
    Arefeh Zabeti Touchaei
    Sogand Vahidi
    Cancer Cell International, 24